Evidence map›Paper›PMID 28570542›Full record

ArticleJournal of visualized experiments : JoVE2017

Expression, Purification, and Antimicrobial Activity of S100A12.

Emmanuel Jackson, Saffron Little, Dana S Franklin, Jennifer A Gaddy, Steven M Damo

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Pathogenic role of S100 proteins in psoriasis.Frontiers in immunology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. S100A12 in Digestive Diseases and Health: A Scoping Review.Gastroenterology research and practice · 2020
    Article
  10. S100 Proteins in the Innate Immune Response to Pathogens.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  11. S100 proteins in rheumatic diseases.Nature reviews. Rheumatology · 2018
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Emmanuel JacksonDepartment of Life and Physical Sciences, Fisk University.
Saffron LittleDepartment of Life and Physical Sciences, Fisk University.
Dana S FranklinDepartment of Life and Physical Sciences, Fisk University.
Jennifer A GaddyTennessee Valley Healthcare Systems, U. S. Dept. of Veterans Affairs; Department of Medicine - Division of Infectious Diseases, Vanderbilt University Medical School; jennifer.a.gaddy@vanderbilt.edu.
Steven M DamoDepartment of Life and Physical Sciences, Fisk University; Department of Biochemistry, Vanderbilt University; sdamo@fisk.edu.
Physical Sciences (United States) · USVA Tennessee Valley Healthcare System · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Fisk University MARC U*STAR ProgramT34GM105551 · NIGMS · FISK UNIVERSITY · PI DAMO, STEVEN, LIMBIRD, LEE E · 2013 to 2022
$1.7M
Regulation of Helicobacter pylori pili encoded by the cag pathogenicity islandIK2BX001701 · VA · VETERANS HEALTH ADMINISTRATION · PI GADDY, JENNIFER A · 2013 to 2017
–
BLRD VA IK2 BX001701NCATS NIH HHS UL1 TR000445NIGMS NIH HHS T34 GM105551
6 · The paper itself

Abstract

Calgranulin proteins are important mediators of innate immunity and are members of the S100 class of the EF-hand family of calcium binding proteins. Some S100 proteins have the capacity to bind transition metals with high affinity and effectively sequester them away from invading microbial pathogens in a process that is termed "nutritional immunity". S100A12 (EN-RAGE) binds both zinc and copper and is highly abundant in innate immune cells such as macrophages and neutrophils. We report a refined method for the expression, enrichment and purification of S100A12 in its active, metal-binding configuration. Utilization of this protein in bacterial growth and viability analyses reveals that S100A12 has antimicrobial activity against the bacterial pathogen, Helicobacter pylori. The antimicrobial activity is predicated on the zinc-binding activity of S100A12, which chelates nutrient zinc, thereby starving H. pylori which requires zinc for growth and proliferation.

Indexed as

Anti-Infective AgentsCopperEscherichia coliHelicobacter pyloriHumansImmunity, InnateS100A12 ProteinZincAnti-Infective AgentsCopperS100A12 ProteinS100A12 protein, humanZinc

Identifiers

PMID28570542
PMCPMC5607942
OpenAlexW2612778511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.